What appeared to be the most momentous scientific advance of the year is currently under siege. In June, the prestigious journal Science published an article by the South Korean scientist Hwang Woo-suk and an international team of co-authors describing how they had developed what were, in effect, "made to order" lines of human stem cells cloned from an adult. Although the scientific validity of their research is now the subject of several separate investigations, it is no less important to examine its ethical implications.
Hwang and his colleagues claimed to have replaced the nucleus of an unfertilized human egg with the nucleus of an ordinary cell taken from another person, developing stem-cell lines from the resulting embryo that matched the DNA of the person who supplied the ordinary cell.
That achievement appeared to take us significantly closer to a world in which patients could be given cell or tissue transplants that their bodies would not reject, because the biological materials, cloned from the patients themselves, would be a perfect match.
At the beginning of this month, Hwang disclosed that some of the eggs came from two women working in his lab, and that other "donors" had been paid for their eggs -- a breach of ethical guidelines that had nothing to do with the accuracy of the science.
But then Hwang's collaborators began questioning the validity of the experiment itself, and Hwang notified Science that he wished to withdraw the paper. At the time of writing, he still defends the validity of his work, while admitting "human errors" in the preservation of the stem-cell lines, including contamination by a fungus. He has reportedly even suggested that some cells may have been tampered with.
We will not know how close we are to the production of individually tailored stem-cell lines until the scientific investigations into Hwang's research are completed. Nevertheless, few researchers doubt that what Hwang and his colleagues claimed to have done is, in principle, achievable. If Hwang was not the first to do it, someone else eventually will be. Once it can be done reliably, it will pave the way for important medical breakthroughs.
But the ethical significance of such research goes far beyond the undoubted importance of saving critically ill patients. Proving the possibility of cloning from the nucleus of an ordinary human cell would transform the debate about the value of potential human life, for we would find that "potential human life" was all around us, in every cell of our bodies.
For example, when US President George W. Bush announced in 2001 that the US would not fund research into new stem-cell lines that are created from human embryos, he offered the following reason: "Like a snowflake, each of these embryos is unique, with the unique genetic potential of an individual human being."
But it is precisely this reasoning that is threatened by what Hwang and his team claimed to have achieved.
If it is the uniqueness of human embryos that makes it wrong to destroy them, then there is no compelling reason not to take one cell from an embryo and destroy the remainder of it to obtain stem cells, for the embryo's "unique genetic potential" would be preserved.
This possibility highlights the weakness of the argument that abortion, too, is wrong because it destroys a genetically unique human being. By this reasoning, a woman who finds herself pregnant at an inconvenient time could have an abortion, as long as she preserves a single cell from the fetus to ensure that its unique genetic potential is preserved.
But it seems absurd that this should make any difference to the morality of aborting the fetus. If, at a later date, the woman wants to have a child, why should she use the DNA of her earlier, aborted fetus rather than conceiving another fetus in the usual way? Each fetus -- the one she aborts and the one she later conceives through sexual intercourse -- has its own "unique" DNA. In the absence of special reasons, like a change in sexual partners, there seems to be no reason to prefer the existence of one child to that of the other.
Perhaps the assumption is that, as opponents of abortion sometimes say, the aborted fetus had the genetic potential to become a Beethoven or an Einstein. But, for all we know, it is the next fetus that the woman will conceive, not the one she aborted, that will turn out to be the Beethoven or Einstein. So why prefer one genetic potential over the other?
Once we abandon arguments based on potential, the claim that it is wrong to kill embryos and fetuses must be based on the nature of those entities themselves -- that they are actual human beings who already possess the characteristics that make killing wrong.
But, because fetuses, at least at the stage of development when most abortions are performed, have yet to develop any kind of consciousness, it seems reasonable to regard ending their lives as much less serious than killing a normal human being. If so, then this is all the more true of embryos.
Peter Singer is professor of bioethics at Princeton University.
Copyright: Project Syndicate
Could Asia be on the verge of a new wave of nuclear proliferation? A look back at the early history of the North Atlantic Treaty Organization (NATO), which recently celebrated its 75th anniversary, illuminates some reasons for concern in the Indo-Pacific today. US Secretary of Defense Lloyd Austin recently described NATO as “the most powerful and successful alliance in history,” but the organization’s early years were not without challenges. At its inception, the signing of the North Atlantic Treaty marked a sea change in American strategic thinking. The United States had been intent on withdrawing from Europe in the years following
My wife and I spent the week in the interior of Taiwan where Shuyuan spent her childhood. In that town there is a street that functions as an open farmer’s market. Walk along that street, as Shuyuan did yesterday, and it is next to impossible to come home empty-handed. Some mangoes that looked vaguely like others we had seen around here ended up on our table. Shuyuan told how she had bought them from a little old farmer woman from the countryside who said the mangoes were from a very old tree she had on her property. The big surprise
The issue of China’s overcapacity has drawn greater global attention recently, with US Secretary of the Treasury Janet Yellen urging Beijing to address its excess production in key industries during her visit to China last week. Meanwhile in Brussels, European Commission President Ursula von der Leyen last week said that Europe must have a tough talk with China on its perceived overcapacity and unfair trade practices. The remarks by Yellen and Von der Leyen come as China’s economy is undergoing a painful transition. Beijing is trying to steer the world’s second-largest economy out of a COVID-19 slump, the property crisis and
Former president Ma Ying-jeou’s (馬英九) trip to China provides a pertinent reminder of why Taiwanese protested so vociferously against attempts to force through the cross-strait service trade agreement in 2014 and why, since Ma’s presidential election win in 2012, they have not voted in another Chinese Nationalist Party (KMT) candidate. While the nation narrowly avoided tragedy — the treaty would have put Taiwan on the path toward the demobilization of its democracy, which Courtney Donovan Smith wrote about in the Taipei Times in “With the Sunflower movement Taiwan dodged a bullet” — Ma’s political swansong in China, which included fawning dithyrambs